Reuters
24 Aug 2026, 11:25 UTC · 3h ago
U.S. court orders Guardant to pay $245 million in DNA sequencing patent dispute
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Reuters
24 Aug 2026, 11:25 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
A U.S. court ordered Guardant Health to pay over $245.2 million to TwinStrand Biosciences and the University of Washington for patent infringement. — A substantial cash outflow and legal defeat create immediate financial liability and potential uncertainty regarding the use of core DNA sequencing technology.
-0.60Which stocks this story touches
The company was ordered to pay over $245 million due to patent infringement.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Business Wire
1h ago
